Skip to main content
Clinical Trials/CTRI/2024/02/063117
CTRI/2024/02/063117
Not yet recruiting
Not Applicable

Correlation of cytological and histo pathological findings in bone lesions :A cross sectional study

Dr Tavleen Bedi1 site in 1 country52 target enrollmentStarted: February 29, 2024Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Dr Tavleen Bedi
Enrollment
52
Locations
1
Primary Endpoint
To classify the bone lesions on the basis of cyto-histomorphological features as per

Overview

Brief Summary

The study will be conducted in Department of Pathology in collaboration with Department of Orthopaedics, Rohilkhand Medical College and Hospital, Bareilly after taking approval from Institutional Ethics Committee and with consent from patient will include all cytological and biopsy specimens of bone lesions received in department in one year duration

PROCEDURE OF FNAC

The informed consent to be taken from the patient as per standard protocol.

The patient’s demographic data including gender, age, comorbid conditions and clinical history such as pain, swelling and relevant radiological investigation record will be maintained

The patient will be explained the details of the procedure, and written consent will be documented.

A thorough clinical examination will be conducted on the patient and details about the lesion or lump (including site, size, consistency, mobility, and tenderness) will be noted.

The procedure (FNA) will be performed under strict aseptic precautions, with prepacked swabs soaked in 70% alcohol.

A sterile needle of 20-21 gauge attached to 20 cc disposable syringe mounted in a syringe holder will be positioned above the superficial lesion and advanced gently to puncture the skin.

Using two fingers of the other hand to keep the lump fixed, the needle will be advanced into the lesion

When sure that the needle tip is inside the target tissue, the plunger will be pulled to apply negative pressure.

Multiple passes will be made without exiting the tissue and the needle moved back and forth in different directions to collect sufficient material.

With the needle still in the target tissue, the negative pressure will be released. The needle will then be withdrawn from the lesion.

Subsequently, the needle will be detached, and air will be drawn into the syringe.

After reattachment of the needle to the syringe, the material will be blown onto several clean glass slides, and smeared using a spreader.

The gross appearance of the aspirate will be recorded.

The slides will be air-dried and stained with Leishman-Giemsa

Study Design

Study Type
Observational

Eligibility Criteria

Ages
1.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ALL CASES OF BONE LESIONS WHO WILL UNDERGO BOTH HISTOPATHOLOGY AND CYTOPATHOLOGY.

Exclusion Criteria

  • BIOPSIES REPORTED AS UNSATISFACTORY FOR EVALUATION CYTOLOGICAL SAMPLES ONLY HAVING BLOODY ASPIRATE.

Outcomes

Primary Outcomes

To classify the bone lesions on the basis of cyto-histomorphological features as per

Time Frame: 4 weeks

WHO classification (2020).

Time Frame: 4 weeks

To categorize the bone lesions on the basis of age, gender and site. To correlate cytological findings with histopathological findings.

Time Frame: 4 weeks

Secondary Outcomes

  • To classify the bone lesions on the basis of cyto-histomorphological features as per(WHO classification (2020).)

Investigators

Sponsor
Dr Tavleen Bedi
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Tavleen Bedi

Rohilkhand medical college and hospital, Pilibhit bypass road, Bareilly

Study Sites (1)

Loading locations...

Similar Trials